Skinhealth Systems Inc (SKIN)

Featured in High-Beta Stocks

SkinHealth Systems Inc. is a common stock listing on NASDAQ for a global medical aesthetics company focused on skin and scalp care solutions. The company offers an integrated portfolio built around its HydraFacial platform, including proprietary cleansing, extraction, and hydration treatments, as well as Syndeo devices, single-use consumables, and related serums and solutions. Its product set also includes the SkinStylus SteriLock Microsystem for microneedling and nanoneedling applications and Keravive peptide solutions and take-home sprays for scalp health. In addition, SkinHealth Systems operates the MyBeautyHealth mobile application, which supports consumer engagement through loyalty features, treatment planning, and provider connections. Founded in 1997 and headquartered in Long Beach, California, the company serves markets across the Americas, Europe, the Middle East, Africa, Canada, Latin America, and the Asia-Pacific region. It was formerly known as The Beauty Health Company and adopted its current name in April 2026.


Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NASDAQ-SKIN
$1.02
32.6% Upside
Undervalued
$1.34
75.2% Upside
Bargain
Fair
0.0%
August 11, 2026
-15.3x
1.8x
0.3x
102.2 M
265.1 M
78.2%
47.9%
-0.9
-434.8%
Valuation • Fair Value

Skinhealth Systems Inc (NASDAQ-SKIN) Fair Value by Valuation Model

Compare the primary fair value estimate for Skinhealth Systems Inc (NASDAQ-SKIN) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$1.02

Estimated upside of 32.6% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

DCF Fair Value

NM

Discounted cash flow valuation reference.

Ben Graham Formula Value

$0

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

$0.55

Earnings power value estimate.

Comps Fair Value

$1.09

Comparable-company valuation reference.

Analyst Price Target

$1.34

Analysts imply upside of 75.2%.

How to read these valuation models

Use this section to compare the primary fair value estimate for Skinhealth Systems Inc (NASDAQ-SKIN) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Skinhealth Systems Inc (NASDAQ-SKIN)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

296.1 M

Current operating scale indicator.

Revenue Forecast

290.9 M

Forward revenue estimate.

EBITDA

13.94 M

Current operating profitability reference.

EBITDA Forecast

41.7 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Skinhealth Systems Inc (NASDAQ-SKIN) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Skinhealth Systems Inc (NASDAQ-SKIN)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Fair

Mixed or neutral financial-health read.

Piotroski Score

6

Mid-range quality score.

Beneish M-Score

-2.96

No elevated caution signal from this screen.

Altman Z-Score

-0.9

Lower score that deserves closer risk review.

FCF / Net Income

-434.8%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Skinhealth Systems Inc (NASDAQ-SKIN). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Skinhealth Systems Inc (NASDAQ-SKIN)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

August 11, 2026

Days to Earnings

21

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

Not available

Data is currently unavailable.

How to read events and dividends

This section helps investors track time-sensitive items for Skinhealth Systems Inc (NASDAQ-SKIN), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Skinhealth Systems Inc (NASDAQ-SKIN) Stock Forecast & Technical Outlook

Review Skinhealth Systems Inc (NASDAQ-SKIN) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Skinhealth Systems Inc (NASDAQ-SKIN) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Skinhealth Systems Inc (NASDAQ-SKIN) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Skinhealth Systems Inc (NASDAQ-SKIN) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Skinhealth Systems Inc (NASDAQ-SKIN) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Skinhealth Systems Inc (NASDAQ-SKIN) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Skinhealth Systems Inc (NASDAQ-SKIN)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Hold

Based on the available recommendation mix, Skinhealth Systems Inc (NASDAQ-SKIN) has a Hold consensus, with 1 buy, 5 hold and 0 sell recommendations in the current data set.

Buy 1
Hold 5
Sell 0
FAQ Fast Investor Answers

Skinhealth Systems Inc (NASDAQ-SKIN) Stock FAQ

Quick answers about Skinhealth Systems Inc (NASDAQ-SKIN) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$1.02
Estimated upside 32.6%
Valuation Rating
Undervalued
Estimated upside of 32.6%
Analyst Target
$1.34
Implied upside 75.2%
Financial Health
Fair
Current financial-health read

The current fair value estimate for Skinhealth Systems Inc (NASDAQ-SKIN) is $1.02. This implies an estimated upside of 32.6% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 32.6% versus the current market price.

The available analyst price target for Skinhealth Systems Inc (NASDAQ-SKIN) is $1.34. The analyst target implies estimated upside of 75.2%.

The current financial health read for Skinhealth Systems Inc (NASDAQ-SKIN) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Skinhealth Systems Inc (NASDAQ-SKIN) is August 11, 2026.

Based on the current data, dividend yield is 0.0%.

The current P/E ratio listed for Skinhealth Systems Inc (NASDAQ-SKIN) is -15.3x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Skinhealth Systems Inc is 102.2 M.

The current enterprise value listed for Skinhealth Systems Inc is 265.1 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Skinhealth Systems Inc is NASDAQ-SKIN, and the stock is listed on NASDAQ.

Skinhealth Systems Inc (NASDAQ-SKIN) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for Skinhealth Systems Inc is 78.2%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Skinhealth Systems Inc is 47.9%. Free float helps investors understand how much of the share base is available for public trading.